Clin2
NCT07503405Possibly a fitNot yet recruiting

Testing a new flu treatment in healthy adults

Influenza

Part of Infections, Lungs & breathing clinical trials.

This study tests an experimental medicine called TRX-100 to see if it can safely treat the flu. Healthy volunteers will be given the flu virus in a controlled setting, then the medicine, to see how well it works.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
165 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You are in good health with no major medical conditions.
  • You weigh at least 110 pounds and have a BMI between 18 and 35.
  • You have not had the flu or the flu vaccine in the last 6 months.
  • You are willing to stay in a quarantine facility for part of the study.
  • If you are a woman who can become pregnant, you must use birth control and have a negative pregnancy test.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07854392Recruiting· Phase 4
Testing a new flu shot in healthy adults

This study tests a new flu vaccine to see how well it helps the body fight off the flu. It is for generally healthy adults aged 18 to 59 who have not had the flu recently.

Shaoxing, Zhejiang
NCT07873671Not yet recruiting· Early Phase 1
Study of a new medicine in healthy volunteers

This study tests a new drug, RLX-2508-102, in healthy people to see how safe it is and how the body handles it. It's an early step to learn if the medicine could be used for future treatments.

Sydney, New South Wales
NCT05332899Recruiting· Phase 1
Flu challenge study in healthy adults to test an investigational approach

This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.

Atlanta, Georgia
NCT07215858Recruiting· Phase 2
Testing a new flu vaccine against H1N1 flu

This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.

Bethesda, Maryland
NCT07110532Recruiting· Phase 1
A study of flu virus exposure in healthy adults

This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.

Baltimore, Maryland
NCT06753474Recruiting· Phase 1
Flu challenge study for healthy adults

This study tests how healthy adults respond to being exposed to a flu virus in a controlled setting. You will be closely monitored and may help researchers learn more about flu and potential treatments.

Atlanta, Georgia

Hear when a new Influenza trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.